GO accession | Term name | Evidence code | Go category |
---|
GO:0055114 |
oxidation-reduction proce ss
|
IBA |
biological process |
GO:0016209 |
antioxidant activity
|
IBA |
molecular function |
GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP a s acceptor
|
ISS |
molecular function |
GO:0001516 |
prostaglandin biosyntheti c process
|
ISS |
biological process |
GO:0055114 |
oxidation-reduction proce ss
|
IEA |
biological process |
GO:0055114 |
oxidation-reduction proce ss
|
IEA |
biological process |
GO:0006693 |
prostaglandin metabolic p rocess
|
IEA |
biological process |
GO:0006633 |
fatty acid biosynthetic p rocess
|
IEA |
biological process |
GO:0006629 |
lipid metabolic process
|
IEA |
biological process |
GO:0001516 |
prostaglandin biosyntheti c process
|
IEA |
biological process |
GO:0016491 |
oxidoreductase activity
|
IEA |
molecular function |
GO:0005737 |
cytoplasm
|
IEA |
cellular component |
GO:0006631 |
fatty acid metabolic proc ess
|
IEA |
biological process |
GO:0005515 |
protein binding
|
IPI |
molecular function |
GO:0005515 |
protein binding
|
IPI |
molecular function |
GO:0005829 |
cytosol
|
IEA |
cellular component |
GO:0098869 |
cellular oxidant detoxifi cation
|
IEA |
biological process |
GO:0047017 |
prostaglandin-F synthase activity
|
ISS |
molecular function |
GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP a s acceptor
|
ISS |
molecular function |
GO:0001516 |
prostaglandin biosyntheti c process
|
ISS |
biological process |
GO:0043209 |
myelin sheath
|
ISS |
cellular component |
GO:0005783 |
endoplasmic reticulum
|
ISS |
cellular component |
GO:0005737 |
cytoplasm
|
ISS |
cellular component |
GO:0070062 |
extracellular exosome
|
HDA |
cellular component |